ADAM17 and Alzheimer disease: These in vivo effects are further corroborated by in vitro and in silico studies, where CA exhibited favorable binding to AD-relevant targets such as AChE and TACE (TNF-α converting enzyme), implicating it in both cholinergic and anti-inflammatory regulation [51,52].